Final results from the TRACK-HD study show very specific changes in HD. We're ready for trials: bring on the drugs!
Is access to predictive genetic testing for Huntington's disease a problem? A UBC study says it is.
Levels of the huntingtin protein can be directly measured in blood - could this be useful for gene silencing studies?
A new brain scanning technique reveals high sodium levels in HD brains. How might this help clinical trials?
HD patients are less likely to get cancer, according to a study from Sweden - what does this mean?
European Medicines Agency (EMA) tells NeuroSearch a European license for Huntexil in HD requires another large trial
How can we improve recruitment into Huntington's disease clinical trials? Talking directly with families works!
Intermediate alleles and reduced penetrance – the genetic 'gray area' of Huntington’s disease, explained
Dimebon fails to improve symptoms in HD patients in the HORIZON trial